C

Tactile Systems Technology, Inc. TCMD

$25.99 -$0.43-1.63% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$25.81$26.80
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

TCMD Rating

Reward
Risk

TCMD Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

TCMD Company Overview

Tactile Systems Technology, Inc. (NASDAQ: TCMD), commonly known as Tactile Medical, is a U.S.-based medical technology company focused on developing and commercializing medical devices for chronic disease management in the home setting. The company primarily operates in the durable medical equipment and medical device industries, with a concentration on therapies for lymphedema, chronic venous insufficiency, and pulmonary conditions associated with retained secretions. Its core products are designed to support long-term patient care outside of acute clinical environments, with reimbursement support from Medicare, Veterans Affairs programs, and commercial insurers.

The company’s principal revenue drivers include its proprietary pneumatic compression systems and airway clearance devices. Its flagship products include the Flexitouch system for lymphedema treatment, the Entre system for edema management, and the AffloVest system for airway clearance therapy. Tactile Medical primarily serves patients with chronic conditions, healthcare providers, clinics, and integrated delivery networks across the United States. The company differentiates itself through a clinically focused sales model, reimbursement expertise, and direct patient support infrastructure. Founded in 1995 and headquartered in Minnesota, the company evolved from a niche compression therapy provider into a broader chronic disease management platform through internal product development and acquisitions, including the acquisition of AffloVest assets to expand into respiratory therapy.

Data compiled by narrative technology. May contain errors.
Sector

TCMD Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

TCMD Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

TCMD Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

TCMD Price History

Loading...
52-Week Range32% of range
Current
$25.99
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

TCMD Valuation

Market Cap
Market Cap Rank
#7,731
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

TCMD Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

TCMD Corporate Info

Phone Number
612 355 5100
Address
3701 Wayzata Boulevard
Suite 300
Minneapolis, MN 55416
Country
Year Founded

TCMD Filings

Filing Date
Monday, November 2, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 15 and 19 (est)

TCMD Headlines